"A TREMendous mechanism for Alzheimer's Disease: therapeutic insights"

Add to your list(s) Download to your calendar using vCal

• Dr Damian Crowther, Neuroscience, IMED Biotech Unit, AstraZeneca
• Wednesday 15 November 2017, 10:30-11:30
• Department of Chemistry, Cambridge, Unilever lecture theatre.

If you have a question about this talk, please contact Patrick Flagmeier.

TREM2 is arguably the most potent genetic risk factor for sporadic Alzheimer’s disease. It is a scavenger receptor recognising generic molecular patterns on cellular debris and amyloid fibrils. Reduced levels of TREM2 on the surface of the brain’s phagocytic cells, the microglia, is associated with disease risk. Protecting TREM2 from proteolytic shedding from the microglial surface is a potential therapeutic goal.

This talk is part of the Biophysical Seminars series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• Biophysical Seminar Series 2016/17
• Biophysical Seminars
• Department of Chemistry
• Department of Chemistry, Cambridge, Unilever lecture theatre
• Featured lists
• School of Physical Sciences

Note that ex-directory lists are not shown.